trial or observed group · 2020 · landmark
“With 10 h TRE for 12-weeks, we observed significant reductions in body weight from baseline (−3.30±3.20 kg (−3%), p=0.00028).”
Ten-Hour Time-Restricted Eating Reduces Weight, Blood Pressure, and Atherogenic Lipids in Patients with Metabolic Syndrome. Cell Metab
Who: 19 adults (13 men, 6 women, mean age 59) with metabolic syndrome and baseline eating window >=14 h (mean 15.1 h), most on statins/antihypertensives
PMID 31813824
systematic review · 2021 · landmark
“MADF and the 5:2 diet were the only IF types that were associated with statistically significant weight loss of more than 5% in adults with overweight or obesity.”
Intermittent Fasting and Obesity-Related Health Outcomes: An Umbrella Review of Meta-analyses of Randomized Clinical Trials. JAMA Netw Open
Who: umbrella review of 11 meta-analyses of RCTs in adults with or without medical conditions (mostly overweight/obese)
PMID 34919135
controlled trial · 2023 · landmark
“This randomized clinical trial found that 8-hour TRE without calorie counting was an effective alternative diet strategy for weight loss and lowering of HbA 1c levels compared with daily calorie counting in a sample of adults with T2D and obesity.”
Effect of Time-Restricted Eating on Weight Loss in Adults With Type 2 Diabetes: A Randomized Clinical Trial. JAMA Netw Open
Who: 75 adults aged 18-80 with type 2 diabetes (HbA1c 6.5-11.0%) and obesity (BMI 30-50), mean age 55, 71% women, 53% non-Hispanic Black, 40% Hispanic White
PMID 37889487
other primary study · 2024 · landmark
“In our study, we found no perceptible alteration in fasting glucose levels.”
Intermittent fasting and health outcomes: an umbrella review of systematic reviews and meta-analyses of randomised controlled trials. EClinicalMedicine
Who: Adults (healthy, overweight/obese, prediabetes, type 2 diabetes, metabolic syndrome, NAFLD and others) in RCTs pooled by 23 meta-analyses of intermittent fasting vs CER or non-intervention diets
PMID 38500840
systematic review · 2025 · landmark
“While our analysis did not examine specific eating time windows, these findings were generally consistent with our results for TRE versus ad-libitum diet showing a benefit in fasting blood glucose, insulin resistance (HOMA-IR), and diastolic blood pressure.”
Intermittent fasting strategies and their effects on body weight and other cardiometabolic risk factors: systematic review and network meta-analysis of randomised clinical trials. BMJ
Who: adults, median age 45, mostly overweight/obesity, in RCTs of intermittent fasting, continuous energy restriction or ad-libitum diets
PMID 40533200
controlled trial · 2025 · landmark
“Using an intention‐to‐treat approach with imputed outcomes for missing measures, we found that a 12‐week TRE intervention (8 h, self‐selected eating window) in patients with obesity shortened the eating window and reduced weight relative to baseline but did not improve weight, caloric intake, body composition, resting energy expenditure, metabolic flexibility, or glycemic measures compared with CR or UE.”
Time-restricted eating, caloric reduction, and unrestricted eating effects on weight and metabolism: a randomized trial. Obesity (Silver Spring)
Who: adults aged 18-65 with obesity (BMI 30-55) without diabetes and baseline eating window >= 12 h
PMID 39973006